Loading...
  • renal
  • clearance may be reduced by about 50% in patients with severe renal failure. (drugs.com)
  • If increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. (drugs.com)
  • hypokalemia
  • Hypoglycemia, hypokalemia, lipodystrophy and hypersensitivity are among the potential clinical adverse effects associated with the use of all insulins. (drugs.com)
  • episodes
  • LAR depot suspension: Long-term treatment of severe diarrhea and flushing episodes associated with metastatic carcinoid tumors. (drugs.com)
  • Long-acting suspension is used for long-term management of severe diarrhea and flushing episodes associated with metastatic carcinoid tumors in patients in whom initial treatment with octreotide immediate-release injection has been shown to be effective and tolerated (designated an orphan drug by FDA for this use). (drugs.com)
  • Sandostatin (octreotide acetate) is indicated for the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease. (rxlist.com)
  • Not all episodes of hypoglycemia can be prevented. (rochester.edu)
  • acute
  • She developed severe acute kidney injury with acute tubular necrosis, subnephrotic ranged proteinuria and tubulointerstitial nephritis for which she underwent haemodialysis three times along with other measures of resuscitation. (biomedcentral.com)
  • In our patient, Zinc phosphide poisoning caused severe acute kidney injury, abnormal liver profile, pancreatitis and possible myocarditis. (biomedcentral.com)
  • Symptomatic
  • Symptomatic treatment to suppress or inhibit severe diarrhea and flushing associated with carcinoid tumors. (drugs.com)
  • CONCLUSIONS Medium-chain triglyceride ingestion improves cognition without adversely affecting adrenergic or symptomatic responses to hypoglycemia in intensively treated type 1 diabetic subjects. (diabetesjournals.org)
  • patient
  • By permitting the patient to recognize when he is in a state of either hypo- or hyperglycemia, this monitoring enables the patient to appropriately intervene to maintain his health. (google.co.uk)
  • As this may occur while the patient is asleep, monitoring methods that require action on the patient's part leave the patient vulnerable during his sleep. (google.co.uk)
  • As diabetes develops and symptoms increase, hyperglycemia becomes progressive but will occur only occasionally in the carefully managed diabetic patient. (encyclopedia.com)